
iRhythm Technologies (IRTC) Stock Forecast & Price Target
iRhythm Technologies (IRTC) Analyst Ratings
Bulls say
iRhythm Holdings is an innovative healthcare company with a recent acquisition that is expected to drive revenue and market share growth, combined with a strong financial performance. Despite concerns about competition and reimbursement changes, the company has a positive outlook due to plans for expansion and partnerships, particularly with their Zio MCT product. Raised revenue guidance and positive analyst recommendations further support a favorable outlook for the company.
Bears say
iRhythm Holdings is a digital healthcare company that has shown strong revenue growth and profitability potential thanks to its innovative device-based technology and strong market position in the extended-wear cardiac monitoring industry. However, potential risks, such as lower commercial reimbursement rates, competition from existing players, potential FDA warning letters, and delays in key product launches, may hinder the company's growth and impact its profitability in the long run. Further growth drivers, including expansion into the asymptomatic AF space and international markets, exist, but may take longer to materialize than currently anticipated.
This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.
iRhythm Technologies (IRTC) Analyst Forecast & Price Prediction
Start investing in iRhythm Technologies (IRTC)
Order type
Buy in
Order amount
Est. shares
0 shares